Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osvaldo Messina

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Reumatologia Clinica|April 2, 2023
Rheumatological adverse events secondary to immune checkpoint inhibitorsMaría Cecilia Garbarino, Natalia Manzano, Osvaldo Messina, et al.
Clinical Rheumatology|June 25, 2021
Refractory fibromyalgiaLuis F Vidal, Osvaldo Messina, Tamara Rodríguez, et al.
The Journal of Clinical Endocrinology and Metabolism|November 19, 2020
Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney DiseaseAaron Broadwell, Arkadi Chines, Peter R Ebeling, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Reumatologia Clinica|April 2, 2023
Rheumatological adverse events secondary to immune checkpoint inhibitorsMaría Cecilia Garbarino, Natalia Manzano, Osvaldo Messina, et al.
Clinical Rheumatology|June 25, 2021
Refractory fibromyalgiaLuis F Vidal, Osvaldo Messina, Tamara Rodríguez, et al.
The Journal of Clinical Endocrinology and Metabolism|November 19, 2020
Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney DiseaseAaron Broadwell, Arkadi Chines, Peter R Ebeling, et al.
Pageof 1